Office of the Director, National Institutes of Health; Notice of Closed Meeting, 38651-38652 [06-6046]
Download as PDF
38651
Federal Register / Vol. 71, No. 130 / Friday, July 7, 2006 / Notices
residues in cattle kidney tissue. The
U.S. Department of Agriculture, Food
Safety Quality Service (now known as
the Food Safety Inspection Service)
agreed to report any detectable residues
in other edible tissue and to report to
FDA only those cattle kidney tissue
reports where the streptomycin residue
was 2 ppm or more.
Since issuing this CPG, FDA has
established tolerances for
dihydrostreptomycin (59 FR 41976,
August 16, 1994) and streptomycin (58
FR 47210, September 8, 1993).
Tolerances are established for residues
of dihydrostreptomycin in uncooked,
edible tissues of cattle and swine of 2.0
ppm in kidney and 0.5 ppm in other
tissues, and 0.125 ppm in milk. (See 21
CFR 556.200.) Tolerances are
established for residues of streptomycin
in uncooked, edible tissues of chickens,
swine, and calves of 2.0 ppm in kidney,
and 0.5 ppm in other tissues. (See 21
CFR 556.610.)
FDA is withdrawing CPG 7125.22, in
its entirety, to eliminate obsolete
compliance policy.
Dated: June 20, 2006.
Margaret O’K. Glavin,
Associate Commissioner for Regulatory
Affairs.
[FR Doc. E6–10671 Filed 7–6–06; 8:45 am]
Proposed Project: The Health Education
Assistance Loan (HEAL) Program:
Forms (OMB No. 0915–0034 Extension)
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, call the HRSA Reports
Clearance Office on (301) 443–1129.
The following request has been
submitted to the Office of Management
and Budget for review under the
Paperwork Reduction Act of 1995:
Responses
per
respondent
Number of
respondents
Collection activity
The HEAL program provides federally
insured loans to assure the availability
of funds for loans to eligible students to
pay for their education costs. In order to
administer and monitor the HEAL
program, the following forms are
utilized: The Application for Contract of
Federal Loan Insurance form (used by
lenders to make application to the
HEAL insurance program and formerly
entitled Lenders Application for
Contract of Federal Loan Insurance
form); the Borrower’s Deferment
Request form (used by borrowers to
request deferments on HEAL loans and
used by lenders to determine borrower’s
eligibility for deferment); the Borrower
Loan Status update electronic
submission (submitted monthly by
lenders to the Secretary on the status of
each loan); and the Loan Purchase/
Consolidation electronic submission
(submitted by lenders to the Secretary to
report sales, and purchases of HEAL
loans).
The estimates of burden for the forms
are as follows:
Total
responses
Hours per
response
Total burden
hours
Application for Contract of Federal Loan Insurance ..............
Borrower’s Deferment Request:
Borrowers ........................................................................
Employers .......................................................................
Borrower Loan Status Update ................................................
Loan Purchase/Consolidation ................................................
17
1
17
8 min ...........
3
436
261
8
17
1
1.669
18
248
436
436
144
4,216
10 min .........
5 min ...........
10 min .........
4 min ...........
73
36
24
281
Total ................................................................................
739
........................
5,249
.....................
417
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to:
John Kraemer, Human Resources and
Housing Branch, Office of Management
and Budget, New Executive Office
Building, Room 10235, Washington, DC
20503.
cprice-sewell on PROD1PC66 with NOTICES
Dated: June 29, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–10591 Filed 7–6–06; 8:45 am]
BILLING CODE 4165–15–P
VerDate Aug<31>2005
17:24 Jul 06, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Advisory Committee to the Director,
National Institutes of Health (NIH).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
and personal information concerning
individuals associated witht he grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal property.
Name of Committee: Advisory Committee
to the Director, NIH.
Date: August 17, 2006.
Time: 2 p.m. to 3 p.m.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Room 5B64,
Bethesda, MD 20892.
Agenda: To review and evaluate grant
applications (Telephone Conference Call).
Contact Person: Shelly Pollard, ACD
Coordinator, National Institutes of Health,
9000 Rockville Pike, Building 31, Room
5B64, Bethesda, MD 20892, (301) 496–0959,
pollards@mail.nih.gov.
E:\FR\FM\07JYN1.SGM
07JYN1
38652
Federal Register / Vol. 71, No. 130 / Friday, July 7, 2006 / Notices
Dated: June 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6046 Filed 7–6–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
cprice-sewell on PROD1PC66 with NOTICES
Name of Committee: National Institute of
Mental Health Special Emphasis Panel, T32
Training Applications in NeuroAIDS.
Date: July 18, 2006.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Peter J. Sheridan, PhD.,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1513,
psherida@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.242, Mental
Health Research Grants; 93.281,
Scientist Development Award, Scientist
Development Award for Clinicians, and
Research Scientist Award; 93.282,
Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Postdoctoral Research and Training.
Date: July 20, 2006.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, 45 Center Drive—Room 3AS–13,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Brian R Pike, PhD., Office
of Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20892, 301–594–3907,
pikbr@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.375,
Minority Biomedical Research Support;
93.821, Cell Biology and Biophysics
Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers;
93.96, Special Minority Initiatives,
National Institutes of Health, HHS)
Dated: June 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6040 Filed 7–6–06; 8:45 am]
Dated: June 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–6041 Filed 7–6–06; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
VerDate Aug<31>2005
15:46 Jul 06, 2006
Jkt 208001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associate with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Membrane
Trafficking in Epithelial Cells.
Date: July 25, 2006.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Wellner, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes
Health, Room 706, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452,
rw175w@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Hematopoietic Cell
Transplantation.
Date: July 27, 2006.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Wellner, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes
Health, Room 706, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452.
rw175w@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\07JYN1.SGM
07JYN1
Agencies
[Federal Register Volume 71, Number 130 (Friday, July 7, 2006)]
[Notices]
[Pages 38651-38652]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6046]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Advisory Committee to the Director, National Institutes of Health
(NIH).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated witht he grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal property.
Name of Committee: Advisory Committee to the Director, NIH.
Date: August 17, 2006.
Time: 2 p.m. to 3 p.m.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Room 5B64, Bethesda, MD 20892.
Agenda: To review and evaluate grant applications (Telephone
Conference Call).
Contact Person: Shelly Pollard, ACD Coordinator, National
Institutes of Health, 9000 Rockville Pike, Building 31, Room 5B64,
Bethesda, MD 20892, (301) 496-0959, pollards@mail.nih.gov.
[[Page 38652]]
Dated: June 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6046 Filed 7-6-06; 8:45 am]
BILLING CODE 4140-01-M